JHS — JHS Svendgaard Laboratories Share Price
- IN₹1.15bn
- IN₹1.13bn
- IN₹707.98m
- 33
- 44
- 21
- 21
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.65 | ||
Price to Tang. Book | 0.66 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.33 | ||
EV to EBITDA | 52.32 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -3.04% | ||
Return on Equity | -7.69% | ||
Operating Margin | -6.36% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 1,391.14 | 1,007.65 | 862.52 | 962.07 | 707.98 | n/a | n/a | -10.62% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | -75.19 | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
JHS Svendgaard Laboratories Limited is an India-based private label manufacturer of oral care products. The Company is engaged in manufacturing a range of oral and dental products for national and international brands. The Company is involved in the manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanitizers and job work of detergent powder. Its domestic market products include toothbrushes, toothpaste, mouthwash, laundry sanitizer, and room fresheners. Its international market products include toothbrush, toothpaste and denture tablet. The Company’s subsidiary is JHS Svendgaard Mechanical and Warehouse Private Limited.
Directors
- Ashish Goel CFO (32)
- Neeraj Kumar CFO
- Avinash Pratap CCO
- Nikhil Nanda MDR
- Nikhil Vora DRC
- Kapil Minocha IND
- Mukul Pathak IND (52)
- Rohina Sangtani IND (52)
- Rajagopal Venkateish IND
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 8th, 2004
- Public Since
- October 19th, 2006
- No. of Shareholders
- 26,448
- No. of Employees
- 250
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
National Stock Exchange of India
- Shares in Issue
- 85,603,966

- Address
- B-1/E-23 Mohan Co-Op, NEW DELHI, 110044
- Web
- https://www.svendgaard.com/
- Phone
- +91 1126900411
- Contact
- Chetan Batra
- Auditors
- TATTVAM & Co.
Upcoming Events for JHS
Q1 2026 JHS Svendgaard Laboratories Ltd Earnings Release
JHS Svendgaard Laboratories Ltd Annual Shareholders Meeting
Similar to JHS
Ambica Agarbathies Aroma & Industries
National Stock Exchange of India
Bajaj Consumer Care
National Stock Exchange of India
CL Educate
National Stock Exchange of India
Colgate-Palmolive (India)
National Stock Exchange of India
CP Capital
National Stock Exchange of India
FAQ
As of Today at 21:27 UTC, shares in JHS Svendgaard Laboratories are trading at IN₹13.74. This share price information is delayed by 15 minutes.
Shares in JHS Svendgaard Laboratories last closed at IN₹13.74 and the price had moved by -24.38% over the past 365 days. In terms of relative price strength the JHS Svendgaard Laboratories share price has underperformed the S&P BSE 100 Index by -28.77% over the past year.
The overall consensus recommendation for JHS Svendgaard Laboratories is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreJHS Svendgaard Laboratories does not currently pay a dividend.
JHS Svendgaard Laboratories does not currently pay a dividend.
JHS Svendgaard Laboratories does not currently pay a dividend.
To buy shares in JHS Svendgaard Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹13.74, shares in JHS Svendgaard Laboratories had a market capitalisation of IN₹1.15bn.
Here are the trading details for JHS Svendgaard Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: JHS
Based on an overall assessment of its quality, value and momentum JHS Svendgaard Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like JHS Svendgaard Laboratories. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -42%.
As of the last closing price of IN₹13.74, shares in JHS Svendgaard Laboratories were trading -35.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The JHS Svendgaard Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹13.74.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
JHS Svendgaard Laboratories' management team is headed by:
- Ashish Goel - CFO
- Neeraj Kumar - CFO
- Avinash Pratap - CCO
- Nikhil Nanda - MDR
- Nikhil Vora - DRC
- Kapil Minocha - IND
- Mukul Pathak - IND
- Rohina Sangtani - IND
- Rajagopal Venkateish - IND